CCND1 and endometrioid adenocarcinoma: The positive rate of the CyclinD1 expression was 30.0%, 49.0%, 52%, 38% and 67% in simple hyperplasia, ACH, endometrioid carcinoma, ESC and CCC each (p > 0.05).